{"id":"https://openalex.org/W3213815459","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.168","title":"168 Expanding and characterizing tumor infiltrating lymphocytes from myxofibrosarcoma and undifferentiated pleomorphic sarcoma","display_name":"168 Expanding and characterizing tumor infiltrating lymphocytes from myxofibrosarcoma and undifferentiated pleomorphic sarcoma","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3213815459","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.168","mag":"3213815459"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.168","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.168","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.168","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A178.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A178.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082543970","display_name":"Jacky H. K. Chen","orcid":"https://orcid.org/0000-0003-0809-8340","observed_orcids":["https://orcid.org/0000-0003-0809-8340"]},"institutions":[{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jacky Chen","raw_affiliation_strings":["Lunenfeld Tanenbaum Research Institute, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lunenfeld Tanenbaum Research Institute, Toronto, Canada","institution_ids":["https://openalex.org/I210557978"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002302013","display_name":"Jay Steven Wunder","orcid":"https://orcid.org/0000-0002-5978-9400","observed_orcids":["https://orcid.org/0000-0002-5978-9400"]},"institutions":[{"id":"https://openalex.org/I4210130843","display_name":"Sinai Health System","ror":"https://ror.org/044790d95","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jay Wunder","raw_affiliation_strings":["Sinai Health System, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Health System, Toronto, Canada","institution_ids":["https://openalex.org/I4210130843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061083720","display_name":"Kim M. Tsoi","orcid":"https://orcid.org/0000-0003-4329-2333","observed_orcids":["https://orcid.org/0000-0003-4329-2333"]},"institutions":[{"id":"https://openalex.org/I4210130843","display_name":"Sinai Health System","ror":"https://ror.org/044790d95","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kim Tsoi","raw_affiliation_strings":["Sinai Health System, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sinai Health System, Toronto, Canada","institution_ids":["https://openalex.org/I4210130843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084980524","display_name":"Nalan G\u00f6kg\u00f6z","orcid":"https://orcid.org/0000-0003-3229-1837","observed_orcids":["https://orcid.org/0000-0003-3229-1837"]},"institutions":[{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Nalan Gokgoz","raw_affiliation_strings":["Lunenfeld Tanenbaum Research Institute, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lunenfeld Tanenbaum Research Institute, Toronto, Canada","institution_ids":["https://openalex.org/I210557978"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051193305","display_name":"Irene Louise Andrulis","orcid":"https://orcid.org/0000-0002-4226-6435","observed_orcids":["https://orcid.org/0000-0002-4226-6435"]},"institutions":[{"id":"https://openalex.org/I210557978","display_name":"Lunenfeld-Tanenbaum Research Institute","ror":"https://ror.org/01s5axj25","country_code":"CA","type":"facility","lineage":["https://openalex.org/I1291836623","https://openalex.org/I210557978","https://openalex.org/I4210130843"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Irene Andrulis","raw_affiliation_strings":["Lunenfeld Tanenbaum Research Institute, Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lunenfeld Tanenbaum Research Institute, Toronto, Canada","institution_ids":["https://openalex.org/I210557978"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33523132,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A178","last_page":"A179"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.3176000118255615,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.3176000118255615,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.22689999639987946,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.17270000278949738,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9760000109672546},{"id":"https://openalex.org/keywords/myxofibrosarcoma","display_name":"myxofibrosarcoma","score":0.9919999837875366},{"id":"https://openalex.org/keywords/malignant-fibrous-histiocytoma","display_name":"malignant fibrous histiocytoma","score":1.0},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.7239999771118164},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.9430000185966492},{"id":"https://openalex.org/keywords/til-expansion","display_name":"TIL expansion","score":0.9380000233650208},{"id":"https://openalex.org/keywords/rapid-expansion-protocol","display_name":"rapid expansion protocol","score":0.8859999775886536},{"id":"https://openalex.org/keywords/gamma-chain-cytokines","display_name":"gamma chain cytokines","score":0.8889999985694885},{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.8619999885559082},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.7400000095367432},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.7512122392654419},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.7169272899627686},{"id":"https://openalex.org/C2910450773","wikidata":"https://www.wikidata.org/wiki/Q53907631","display_name":"Myxofibrosarcoma","level":3,"score":0.6644580364227295},{"id":"https://openalex.org/C2910096961","wikidata":"https://www.wikidata.org/wiki/Q1887348","display_name":"Undifferentiated Pleomorphic Sarcoma","level":4,"score":0.572952389717102},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.554919421672821},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5484666228294373},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46819600462913513},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.458530068397522},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.4250369369983673},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4096875488758087},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23265081644058228},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2165142297744751},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2122623324394226}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.168","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.168","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.168","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A178.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:5afa3c74b46a443abbee4b55aa145a5c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/5afa3c74b46a443abbee4b55aa145a5c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.168","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.168","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.168","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A178.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3213815459.pdf","grobid_xml":"https://content.openalex.org/works/W3213815459.grobid-xml"},"referenced_works_count":1,"referenced_works":["https://openalex.org/W3010990547"],"related_works":["https://openalex.org/W3101688455","https://openalex.org/W7133088234","https://openalex.org/W4282979332","https://openalex.org/W7001351532","https://openalex.org/W2891363149","https://openalex.org/W4212916227","https://openalex.org/W2774443002","https://openalex.org/W3120422386","https://openalex.org/W2589024016","https://openalex.org/W7098343484"],"abstract_inverted_index":{"Background":[0],"Sarcoma":[1,67,314],"is":[2,79,277],"a":[3,253,293,338],"group":[4],"of":[5,25,119,173,309,372,379,394],"rare":[6,136,196,345],"bone":[7],"and":[8,55,69,73,114,137,180,185,266,297,320,369,423,436],"soft":[9],"tissue":[10],"tumors":[11,72,177],"with":[12,81,121,203,217,252,264,275,292,333,426],"over":[13],"50":[14],"distinct":[15],"subtypes.":[16],"Survival":[17],"rate":[18,256],"ranges":[19],"widely":[20],"due":[21,39],"to":[22,40,129,139,149,154,194,279,307,318,343,360,433],"the":[23,99,105,169,191,226,328,354,377,392],"lack":[24],"efficacious":[26],"treatments.":[27,270,287,398],"Immunotherapy,":[28],"such":[29],"as":[30,454],"adoptive":[31],"cell":[32,282],"therapy":[33],"(ACT),":[34],"has":[35],"drawn":[36],"significant":[37],"interest":[38],"its":[41],"minimal":[42],"toxicity.":[43],"In":[44,271],"ACT,":[45,272],"tumor":[46],"infiltrating":[47],"lymphocytes":[48],"(TILs)":[49],"are":[50,112,135,316],"isolated":[51],"from":[52,248],"patients,":[53],"expanded,":[54,231],"autologously":[56],"infused":[57],"back.":[58],"We":[59,108,146,188,288,351],"recently":[60],"observed":[61],"TILs\u2019":[62],"presence":[63],"in":[64,85,98,182,285,331,340,396],"Undifferentiated":[65],"Pleomorphic":[66],"(UPS)":[68],"Myxofibrosarcoma":[70],"(MFS)":[71],"found":[74],"that":[75,110,290,308],"tumor\u2019s":[76],"PD-L1":[77,123,159,382],"overexpression":[78],"correlated":[80],"better":[82],"clinical":[83,130,286,434],"outcome":[84,435],"UPS":[86,120,250,259,373,385],"but":[87],"not":[88],"MFS.1":[89],"The":[90],"Th1":[91,437],"anti-tumoral":[92],"inflammatory":[93],"pathway":[94,438],"was":[95,161,207],"highly":[96],"activated":[97],"former":[100],"cohort,":[101],"which":[102,125,141],"may":[103,126],"explain":[104],"favorable":[106],"outcome.":[107],"hypothesize":[109],"there":[111],"phenotypic":[113,368],"functional":[115,370],"differences":[116],"between":[117],"TILs":[118,134,153,214,247,260,374],"differential":[122,381],"expression,":[124],"be":[127],"related":[128],"outcomes.":[131],"However,":[132],"sarcoma":[133,152,197,346,397],"challenging":[138],"culture,":[140,319],"significantly":[142],"impedes":[143],"their":[144,321],"studies.":[145],"first":[147],"aim":[148],"robustly":[150],"expand":[151,195,344],"sufficient":[155,235],"numbers.":[156],"Methods":[157],"Tumors\u2019":[158],"expression":[160,383],"determined":[162],"by":[163,456],"RT-qPCR":[164],"(table":[165],"1).":[166],"To":[167],"initiate":[168],"tumor-fragment":[170],"(TF)":[171],"method":[172],"TIL":[174,229,304,365],"culturing,":[175],"primary":[176],"were":[178,215,261],"fragmented":[179],"cultured":[181],"IMDM,":[183],"IL-2,":[184],"10%":[186],"HSA.":[187],"further":[189,262],"optimized":[190,243],"TF":[192,244,329],"protocol":[193,201,245,330],"TILs.":[198],"Rapid":[199],"expansion":[200],"(REP)":[202],"anti-CD3/anti-CD28":[204],"co-stimulating":[205],"beads":[206],"employed":[208],"for":[209,238,356],"additional":[210],"expansion.":[211,366],"During":[212],"REP,":[213],"co-treated":[216],"gamma-chain":[218,268,358],"cytokines":[219,359],"(IL-2,":[220],"7,":[221],"15,":[222,296],"21).":[223],"Results":[224],"Of":[225],"15":[227],"MFS":[228],"populations":[230],"only":[232],"40%":[233],"achieved":[234],"growth":[236],"(1x106)":[237],"analysis":[239],"(figure":[240,257,311],"1A).":[241],"Our":[242],"expanded":[246],"8":[249],"cases":[251],"62.5%":[254],"success":[255],"1B).":[258],"stimulated":[263],"REP":[265],"various":[267],"cytokine":[269],"prolonged":[273],"culturing":[274],"IL-2":[276,310,363],"known":[278],"cause":[280],"activation-induced":[281],"death,":[283],"problematic":[284],"demonstrated":[289,353],"treatments":[291],"Trio-cocktail":[294],"(IL-7,":[295],"21)":[298],"or":[299],"IL-15":[300],"alone":[301],"can":[302],"achieve":[303],"proliferation":[305],"comparable":[306],"2).":[312],"Conclusions":[313],"infiltrates":[315],"difficult":[317],"roles":[322],"remain":[323],"largely":[324],"unstudied.":[325],"By":[326],"optimizing":[327],"conjunction":[332],"anti-CD3/CD28":[334],"treatments,":[335],"we":[336],"developed":[337],"robust":[339],"vitro":[341],"pipeline":[342],"TILs,":[347],"enabling":[348],"downstream":[349],"characterization.":[350],"also":[352],"potential":[355],"alternate":[357],"favorably":[361],"replace":[362],"during":[364],"Future":[367],"evaluation":[371],"would":[375,390],"elucidate":[376],"impact":[378],"tumors\u2019":[380],"on":[384],"patients\u2018":[386],"prognoses.":[387],"These":[388],"findings":[389],"inform":[391],"implementation":[393],"ACT":[395],"References":[399],"Wunder":[400],"J,":[401,405],"Lee":[402],"M,":[403],"Nam":[404],"Lau":[406],"B,":[407,409],"Dickson":[408],"Pinnaduwage":[410],"D,":[411],"Bull":[412],"S,":[413],"Ferguson":[414],"P,":[415],"Seto":[416],"A,":[417],"Gokgoz":[418],"N,":[419],"Andrulis":[420],"I.":[421],"Osteosarcoma":[422],"soft-tissue":[424],"sarcomas":[425],"an":[427],"immune":[428],"infiltrate":[429],"express":[430],"PD-L1:":[431],"relation":[432],"activation.":[439],"Onco":[440],"Immunology":[441],"2020;9:":[442],"e1737385-1-":[443],"e1737385-13.":[444],"Ethics":[445,460],"Approval":[446],"Patients":[447],"provided":[448],"signed":[449],"consent":[450],"before":[451],"study":[452],"entry,":[453],"approved":[455],"Mount":[457],"Sinai":[458],"Hospital\u2019s":[459],"Board":[461],"(REB#01-0138-U).":[462]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}